Document:

Exhibit 10.03

  

  

  

  
    Share Transfer and Note Cancellation Agreement

     

    This Share Transfer and Note Cancellation Agreement (this “Agreement”) is made as of April 30, 2020, by and
      between ACM Research, Inc. (“ACM”) and Shengxin (Shanghai) Management Consulting Limited Partnership (“SMC,” and together with ACM, the “Parties”).

     

    Recitals

     

    A.     On March 30, 2018, the Parties, together with ACM Research (Shanghai), Inc. (“ACM Shanghai”), entered into a warrant exercise agreement (the “Warrant Exercise Agreement”) pursuant to which SMC exercised in full an outstanding warrant dated March 14, 2017 to purchase from ACM a total of 397,502 shares (the
      “Initial Warrant Shares”) of ACM’s Class A common stock (“Class A Common Stock”) for an aggregate purchase price of $2,981,259.26, which aggregate purchase price was
      paid by SMC’s issuance of a senior secured promissory note dated March 30, 2018 in the principal amount of $2,981,259.26 made and delivered, upon the order of ACM, to ACM Shanghai (the “SMC Note”).

     

    B.      Pursuant to an equity purchase agreement dated August 14, 2019, ACM acquired from SMC a total of 154,821 of the Initial Warrant Shares for an aggregate purchase price of $2,042,863.10, of
      which purchase price a total of $1,161,157.50 was, in accordance with the terms of the Security Covenant, applied to reduce the principal amount outstanding under the SMC Note to $1,820,101.76.

     

    C.      Pursuant to a note assignment and cancellation agreement dated as of the date hereof among ACM, ACM Shanghai and SMC, ACM Shanghai is assigning and transferring to ACM all of ACM
      Shanghai’s rights, title and interest in and to the SMC Note.

     

    D.     The Parties wish to set forth the terms pursuant to which SMC will transfer the remaining 242,681 of the Initial Warrant Shares currently held by SMC (the “Remaining

        Warrant Shares”) to ACM in exchange for consideration as described herein, subject to all approvals required from regulatory authorities of the People’s Republic of China, prior to the Approval Deadline (as defined below).

     

    In consideration of the mutual covenants and agreements set forth in this Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
      Parties agree as follows:

     

    1.       Surrender of, and Consideration for, Remaining Warrant Shares.

     

    1.1    Surrender. On April 30, 2020 (the “Effective Date”), SMC shall assign, transfer, convey and surrender all of its rights, title and interest in and to the Remaining
        Warrant Shares to ACM, against the consideration set forth in Subsection 1.2. Thereafter, the
        Remaining Warrant Shares shall initially have the status of treasury shares, which are authorized and issued, but not outstanding, shares of Class A Common Stock.

     

    1.2    Consideration. It is intended by the Parties that the consideration deliverable to SMC in exchange for the Remaining Warrant Shares surrendered to ACM in accordance with Subsection 1.1 ̧ as determined in accordance with the procedures set forth in Section 2, shall consist of one of the alternatives set forth in this Subsection 1.2. Any such alternative is subject to, and no such alternative may be implemented without, any and all approvals (the “Required Approvals”) required of governmental department
      and other regulatory bodies of the People’s Republic of China (collectively, the “Regulators”).

     

    
      
        

    

    
    (a)    Alternative A. The following proposed rights and benefits to SMC, as they may be subsequently
      modified in writing pursuant to the request of the Regulators and with the agreement of ACM and SMC, are collectively referred to as the “Alternative A

        Consideration”:

     

    	

          	(i)	
            ACM shall cancel the SMC Note and thereby irrevocably and unconditionally release and forever discharge SMC of and from any and all rights, obligations, promises, agreements, debts, losses, controversies, claims, causes of action,
              liabilities, damages and expenses of any nature whatsoever, whether known or unknown and whether asserted or unasserted, that ACM ever had or may have against SMC arising under the SMC Note;

          

     

    	

          	(ii)	
            ACM shall issue to SMC a warrant to purchase up to 242,681 shares of Class A Common Stock (“New Warrant Shares”) at a purchase price per share of $7.50; and

          

     

    	

          	(iii)	
            ACM shall either (A) amend the Registration Rights Agreement dated as of March 10, 2017 (the “Registration Rights Agreement”), pursuant to which ACM granted to SMC certain incidental, or piggyback, rights to offer and sell any or all of the Initial Warrant Shares pursuant to a registration statement filed under the U.S.
                Securities Act of 1933 (the “Securities Act”), to provide such registration rights to SMC with respect to the New Warrant
                Shares or (B) enter into a registration rights agreement pursuant to which ACM shall grant to SMC registration rights with respect to the New Warrant Shares substantially similar to the registration rights previously granted to SMC under
                the Registration Rights Agreement with respect to the Initial Warrant Shares.

          

     

    (b)    Alternative B. The following proposed rights and benefits to SMC, as they may be subsequently
      modified in writing pursuant to the request of the Regulators and with the agreement of ACM and SMC, are collectively referred to as the “Alternative B

        Consideration”:

     

    	

          	(i)	
            SMC shall deliver to ACM $1,820,101.76 in full satisfaction of its payment and other obligations under the SMC Note;

          

     

    	

          	(ii)	
            ACM shall issue to SMC 242,681 shares of Class A Common Stock (the “New Common Shares”); and

          

     

    	

          	(iii)	
            ACM shall either (A) amend the Registration Rights Agreement pursuant to which ACM granted to SMC certain incidental, or piggyback, rights to offer and sell any or all of the Initial Warrant Shares
                pursuant to a registration statement filed under the Securities Act, to provide such registration rights to SMC with respect to the New Common Shares or (B) enter into a registration rights agreement pursuant to which ACM shall grant to SMC
                registration rights with respect to the New Common Shares substantially similar to the registration rights previously granted to SMC under the Registration Rights Agreement with respect to the Initial Warrant Shares.

          

     

    (c)      New Alternatives. If (a) one or more Regulators propose rights and
      benefits (other than those contemplated by Alternative A Consideration or Alternative B Consideration) for delivery to SMC in consideration for the surrender of the Remaining Warrant Shares to ACM and such rights and benefits are acceptable to, and
      agreed upon by, each of ACM and SMC in their sole discretion or (b) as the result of discussions between the Parties and the Regulators in connection with the Parties’ obtaining of Required Approvals in accordance with Subsection 2.1,
      other rights and benefits to be delivered to SMC in consideration for the surrender of the Remaining Warrant Shares to ACM are proposed that are acceptable to, and agreed upon by, each of ACM and SMC in their sole discretion, each such set of rights
      and benefits shall be collectively referred to as “New Alternative Consideration.”

     

    
      2

      
        

    

    2.       Required Approvals.

     

    2.1    Solicitation of Required Approvals. SMC shall use its reasonable best efforts to obtain the Required Approvals with respect to each of the Alternative A Consideration and the Alternative B Consideration by no later than December
        31, 2023 (such date, as it may be extended from time to time with the written consent of both ACM and SMC, being referred to as the “Approval Deadline”). If, at any time prior to the Approval Deadline, one or more Regulators indicate that neither the Alternative A Consideration nor the Alternative B Consideration will receive any of the Required
        Approvals, then (a) each of ACM and SMC, in cooperation with the Regulators, shall use its reasonable best efforts to identify and develop one or more proposals for New Alternative Consideration, provided that in each case any such New Alternative Consideration shall be subject to the approval of each of ACM and SMC, which approval may be
        withheld in their sole discretion and (b) SMC shall use its reasonable best efforts to obtain the Required Approvals with respect to each such New Alternative
        Consideration by no later than the Approval Deadline.

     

    2.2    Required Approvals Obtained. Upon the receipt of the Required Approvals with respect to one or more of the Alternative A Consideration, the Alternative B Consideration and any New Alternative Consideration, ACM and SMC shall:

     

    	

          	(a)	
            if Required Approvals are received with respect to more than one of the alternative proposals for consideration, within a reasonable time frame but in any event within five
                business days from the earliest date on which both Parties have been notified of the receipt of the Required Approvals, select and agree upon the alternative proposal to be implemented;

          

     

    	

          	(b)	
            reasonably agree on a date for the closing of the selected alternative proposal, which date shall be no more than ten business days from the date the selection pursuant to
                clause (a) is made or, if only one alternative proposal is approved, from the date the notification of such approval is received;

          

     

    	

          	(c)	
            use their reasonable best efforts to obtain any additional consents necessary or reasonably desirable in order to effect the closing and to agree on any additional
                documentation necessary for the delivery of the applicable consideration; and

          

     

    	

          	(d)	
            deliver the consideration contemplated by the selected alternative proposal, together with any additional consents and other documents, and take such other actions, as they
                may deem necessary or reasonably desirable in order to comply with the Required Approvals with respect to the selected alternative proposal.

          

     

    2.3    Required Approval Not Obtained. If, by the Approval Deadline, (a) the Required Approvals have
      not been obtained with respect to at least one of the Alternative A Consideration, the Alternative B Consideration and any New Alternative Consideration and (b) SMC has not otherwise
      reached a new agreement suitable to ACM, SMC and the Regulators with respect to the rights and benefits to be received by SMC as consideration for its surrender of the Remaining Warrant Shares to ACM (an “Updating
        Agreement”), then SMC and ACM hereby acknowledge and agree that the cancellation of the SMC Note by ACM will constitute full satisfaction and payment for SMC’s surrender of the Remaining Warrant Shares to ACM in accordance with Section 1.1
      and, accordingly, the SMC Note shall be cancelled, and shall no longer be outstanding, effective as of 5 p.m., Eastern time, on the Approval Deadline. For clarity, and without limiting the foregoing, at such time and on such date, ACM shall
      automatically, without any further action on the part of ACM or SMC, irrevocably and unconditionally release and forever discharge SMC of and from any and all rights, obligations, promises, agreements, debts, losses, controversies, claims, causes of
      action, liabilities, damages and expenses of any nature whatsoever, whether known or unknown and whether asserted or unasserted, that ACM ever had or may have against SMC arising under the SMC Note.

     

    
      3

      
        

    

    3.       Representations and Warranties of ACM. ACM represents and warrants to SMC as
      follows:

     

    3.1     SMC Note. ACM is the sole owner and holder of the SMC Note and holds beneficial and legal title to the SMC Note free and
      clear of any and all liens or other encumbrances.

     

    3.2    Authorization. All corporate action required to be taken to authorize ACM to enter into and, except to the extent of any additional authorization required with respect to the New
      Alternative Consideration or any Revised Agreement, perform this Agreement has been taken.

     

    3.3    Binding Obligation. This Agreement constitutes a valid and legally binding obligation of ACM, enforceable against ACM in
      accordance with its terms except (a) as limited by (i) applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other laws of general application relating to or affecting the enforcement of creditors’ rights generally
      or (ii) laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (b) with respect to the enforceability of any New Alternative Consideration or any Revised Agreement prior to the receipt of
      any required authorizations.

     

    3.1    Valid Issuance of Class A Common Stock. The New Warrant
        Shares or New Common Shares, as applicable, if and when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and nonassessable, and free of restrictions on
        transfer other than restrictions on transfer under this Agreement and applicable U.S. federal and state securities laws.

     

    3.2    Governmental Consents and Filings. Except as required by the Required Approvals or as may be required with respect to the
      New Alternative Consideration or any Revised Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any national, provincial or local governmental authority of any
      jurisdiction is required to be obtained by ACM in connection with the consummation of the transactions contemplated by this Agreement.

     

    3.3    Compliance with Other Instruments. ACM is not in violation or default (a) of any provisions of its organizational
      documents, (b) of any instrument, judgment, order, writ or decree, (c) under any note, indenture or mortgage, or (d) under any lease, agreement, contract or purchase order to which it is a party or by which it is bound, or, to its knowledge, of any provision of any statute, rule or regulation applicable to ACM, the violation of which would have a material adverse effect on the business, assets (including intangible assets), liabilities, financial
      condition, property or operating results of ACM. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated by this Agreement will not, provided that ACM is
      able to obtain (i) any additional consent that may be required with respect to the New Alternative Consideration or any Revised Agreement and (ii) the consent required by Section 13(m) of the Registration Rights
        Agreement to grant the registration rights contemplated by the Alternative A Consideration and the Alternative B Consideration, result in any such violation or be in conflict with or constitute, with or without the passage of time and giving
      of notice, either (x) a default under any such provision, instrument, judgment, order, writ, decree, contract or agreement or (y) an event that results in the creation of any lien, charge or encumbrance upon any assets of ACM or the suspension,
      revocation, forfeiture, or nonrenewal of any material permit or license applicable to ACM.

     

    
      4

      
        

    

    4.       Representations and Warranties of SMC. SMC represents and warrants to ACM as follows:

     

    4.1    Remaining Warrant Shares. SMC is the sole owner of the Remaining Warrant Shares and holds beneficial and legal title to the
      Remaining Warrant Shares free and clear of any and all liens or other encumbrances. The Remaining Warrant Shares represent all of the equity interests in ACM held by SMC.

     

    4.2    Authorization. All corporate action required to be taken to authorize SMC to enter into and, except to the extent of any
      additional authorization is required with respect to the New Alternative Consideration or any Revised Agreement, perform this Agreement has been taken.

     

    4.3    Binding Obligation. This Agreement constitutes a valid and legally binding obligation of SMC, enforceable against SMC in
      accordance with its terms except (a) as limited by (i) applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other laws of general application relating to or affecting the enforcement of creditors’ rights generally
      or (ii) laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (b) with respect to the enforceability of any New Alternative Consideration or any Revised Agreement prior to the receipt of
      any required authorizations.

     

    4.4   Governmental Consents and Filings. Except as required by the Required Approvals or as may be required with respect to the
      New Alternative Consideration or any Revised Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any national, provincial or local governmental authority of any
      jurisdiction is required to be obtained by SMC in connection with the consummation of the transactions contemplated by this Agreement.

     

    4.5    Compliance with Other Instruments. SMC is not in violation or default (a) of any provisions of its organizational
      documents, (b) of any instrument, judgment, order, writ or decree, (c) under any note, indenture or mortgage, or (d) under any lease, agreement, contract or purchase order to which it is a party or by which it is bound, or, to its knowledge, of any
      provision of any statute, rule or regulation applicable to SMC, the violation of which would have a material adverse effect on the business, assets (including intangible assets), liabilities, financial condition, property or operating results of SMC.
      The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated by this Agreement will not, provided that SMC is able to obtain any additional consent that may
      be required with respect to the New Alternative Consideration or any Revised Agreement, result in any such violation or be in conflict with or constitute, with or without the passage of time and giving of notice, either (x) a default under
      any such provision, instrument, judgment, order, writ, decree, contract or agreement or (y) an event that results in the creation of any lien, charge or encumbrance upon any assets of SMC or the suspension, revocation, forfeiture, or nonrenewal of
      any material permit or license applicable to SMC.

     

    4.6    Purchase Entirely for Own Account. SMC shall acquire, if and when acquired, the New Warrant Shares or New Common Shares, as applicable, for investment for its own account, not as a nominee or
        agent and not with a view to the resale or distribution of any interest in the New Warrant Shares or New Common Shares, as applicable. SMC has no present intention of
        selling, granting any participation in or otherwise distributing any interest in the New Warrant Shares or New Common Shares, as applicable. SMC does not presently have any
        contract, undertaking, agreement or arrangement with any individual or entity to sell, transfer or grant participations to either such individual or entity or any third party, with respect to the New Warrant Shares or New Common Shares, as applicable.

     

      

    
      5

      
        

    

    4.7    Disclosure of Information. SMC has had an opportunity to
        discuss with ACM’s management the business, management and financial affairs of ACM and ACM Shanghai and the terms and conditions of the offering of the New Warrant Shares
        or New Common Shares, as applicable, and SMC has had an opportunity to review ACM Shanghai’s facilities. The foregoing, however, does not limit or modify the representations and warranties of ACM in Section 3 or the right of SMC to rely thereon.

     

    4.8    Restricted Securities. SMC understands that if and when
        issued, the New Warrant Shares or New Common Shares, as applicable, will not have been, and will not be, registered under the Securities Act, by reason of a specific
        exemption from the registration provisions of the Securities Act that depends upon, among other things, the bona fide nature of the investment intent and the accuracy of SMC’s representations as expressed in this Agreement. SMC understands that the
        New Warrant Shares or New Common Shares, as applicable, are “restricted securities” under applicable U.S. federal and state securities laws and that, pursuant to those laws,
        SMC must hold the New Warrant Shares or New Common Shares, as applicable,
        indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available, including a transfer outside of the United
        States in an offshore transaction in compliance with Rule 904 under the Securities Act of (if applicable). SMC acknowledges that ACM has no obligation to register or qualify for resale the New Warrant Shares or New Common Shares, as applicable, except as set forth in Subsections 1.2(a)(iii) and 1.2(b)(iii). SMC further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including the time and manner of sale, the holding period for the New Warrant Shares or New Common Shares, as applicable, and on requirements relating to ACM that are outside of SMC’s control and that ACM is under no obligation, and may not be able, to satisfy.

     

    4.9    Legends. SMC understands that if and when issued,
        (a) the Warrant and (b) the New Warrant Shares or New Common Shares, as applicable, which will be held in book-entry form, may be notated with restrictive legends as ACM and its counsel deem necessary or advisable under applicable law or pursuant to this Agreement, including a legend substantially to the following effect:

     

    “THESE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933. SUCH SECURITIES MAY NOT BE SOLD, PLEDGED, OR TRANSFERRED
      IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION OF THE U.S. SECURITIES ACT OF 1933.”

     

    4.10  Investor Status. SMC is an accredited investor as defined
        in Rule 501(a) of Regulation D promulgated under the Securities Act and is not a U.S. person as defined in Regulation S under the Securities Act and the
        New Warrant Shares or New Common Shares, as applicable, have not been offered or sold within the United States as defined under the Securities Act. At the time of the
        origination of discussion regarding the offer and sale of the New Warrant Shares or New Common Shares, as applicable and the date of the execution and delivery of this
        Agreement, SMC was at all times outside of the United States. SMC has satisfied itself as to the full observance of the laws of its jurisdiction in connection with any invitation to receive the New Warrant
        Shares or New Common Shares, as applicable, or any use of this Agreement, including (a) the legal requirements within its jurisdiction for the purchase of the New Warrant
        Shares or New Common Shares, as applicable, (b) any foreign exchange restrictions applicable to such purchase, (c) any governmental or other consents that may need to be obtained, (d) the income tax and other
        tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale, or transfer of the New Warrant Shares or New Common Shares, as applicable, and
        (e) SMC’s receipt and continued beneficial ownership of the New Warrant Shares or New Common Shares, as applicable, will not violate any applicable securities or other laws
        of SMC’s jurisdiction.

     

    
      6

      
        

    

    5.       Miscellaneous.

     

    5.1    Survival. Unless otherwise set forth in this Agreement, the representations and warranties of each Party contained in this
      Agreement shall survive the execution and delivery of this Agreement and shall in no way be affected by any investigation or knowledge of the subject matter thereof made by or on behalf of the other Party.

     

    5.2    Successors and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the
      respective successors and assigns of the Parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the Parties to this Agreement or their respective successors and assigns any rights, remedies,
      obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

     

    5.3    Governing Law. This Agreement and any controversy arising out of or relating to this Agreement shall be governed by and
      construed in accordance with the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be governed by and construed in accordance with the internal laws of the State of Delaware,
      without regard to conflict of law principles that would result in the application of any law other than the law of the State of Delaware.

     

    5.4     Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which
      together shall constitute one and the same instrument. Counterparts may be delivered via electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g.,
      www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

     

    5.5     Interpretation. For purposes of this Agreement:

     

    	

          	(a)	
            headings used in this Agreement are for convenience of reference only and shall not, for any purpose, be deemed a part of this Agreement;

          

     

    	

          	(b)	
            references to a Section or Subsection refer to a Section or Subsection of this Agreement, unless specified otherwise;

          

     

    	

          	(c)	
            the words “include” and “including” shall not be construed so as to exclude any other thing not referred to or described;

          

     

    	

          	(d)	
            the word “or” is not exclusive;

          

     

    	

          	(e)	
            the definition given for any term shall apply equally to both the singular and plural forms of the term defined;

          

     

    	

          	(f)	
            unless the context otherwise requires otherwise, references (i) to an agreement, instrument or other document (including this Agreement) mean such agreement, instrument or other document as amended, supplemented and modified from time to
              time to the extent permitted by the provisions thereof and (ii) to a statute mean such statute as amended from time to time and include any successor legislation thereto and any rules and regulations promulgated
              thereunder; and

          

     

    
      7

      
        

    

    	

          	(g)	
            this Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted.

          

     

    5.6    Notices. All notices and other communications given or made pursuant to this Agreement shall
      be in writing and shall be deemed effectively given upon the earlier of (a) personal delivery to, or other actual receipt by, the Party to be notified and (b) when sent, if sent by electronic mail during normal business hours of the recipient, or, if
      not sent during the recipient’s normal business hours, then on the recipient’s next business day. All communications shall be sent to the respective Parties at their addresses or e-mail addresses as set forth on the signature page, or to such address
      or e-mail address as subsequently modified by written notice given in accordance with this Subsection 5.6. If notice is given to ACM, a copy shall also be sent to Mark L. Johnson at K&L Gates LLP, State Street Financial Center, 1 Lincoln
      Street, Boston, Massachusetts 02111.

     

    5.7    Attorneys’ Fees. If any action at law or in equity (including arbitration) is necessary to enforce or interpret the terms
      of any of this Agreement, the prevailing Party shall be entitled to reasonable attorneys’ fees, costs and disbursements in addition to any other relief to which such Party may be entitled.

     

    5.8     Amendments. Any term of this Agreement may be amended or terminated only with the written consent of the Parties.

     

    5.9    Severability. In case any one or more of the provisions contained in this Agreement is for any reason held to be invalid,
      illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be reformed and construed so that it will be
      valid, legal, and enforceable to the maximum extent permitted by law.

     

    5.10  Entire Agreement. This Agreement constitutes the full and entire understanding and agreement between the Parties with
      respect to the subject matter of this Agreement, and any other written or oral agreement relating to the subject matter of this Agreement existing between the Parties is expressly canceled.

     

    5.11   Dispute Resolution.

     

    (a)     The Parties (a) irrevocably and unconditionally submit to the jurisdiction of the state courts of the State of Delaware and to
      the jurisdiction of the U.S. District Court for the District of Delaware for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out
      of or based upon this Agreement except in the state courts of Delaware or the U.S. District Court for the District of Delaware, and (c) waive, and agree not to assert, by way of motion, as a defense, or
      otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is
      brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter of this Agreement may not be enforced in or by such court.

     

    
      8

      
        

    

    (b)     Waiver of Jury Trial: Each Party
        waives its rights to a jury trial of any claim or cause of action based upon or arising out of this Agreement or the subject matter of this Agreement. The scope of this waiver is intended to be all-encompassing of any and all disputes that may be
        filed in any court and that relate to the subject matter of this transaction, including contract claims, tort claims (including negligence), breach of duty claims, and all other common law and statutory claims. This Subsection 5.11(b) has been fully discussed by each of the Parties and these provisions will not be subject to any exceptions. Each Party further warrants and represents that it has reviewed this waiver with its legal counsel, and that
        such Party knowingly and voluntarily waives its jury trial rights following consultation with legal counsel.

     

    [Remainder of Page Intentionally Left Blank]

     

    
      9

      
        

    

    In Witness Whereof, the Parties have executed this Agreement as of the date first written above.

     

    
      	
              

              

            	
              
                ACM Research, Inc.

              

            
	 	 
	

            	
              By:

            	
              /s/ Hui Wang

            
	
              

              

            	 	
              
                Name: Hui Wang

              

            
	 	 	
              
                Title: CEO

              

            

      

      

      
        
          	
                   

                	
                  Address:

                	
                  42307 Osgood Road, Suite I

                
	
                   

                	
                  Fremont, CA 94539

                
	
                   

                	
                  
                    
                      United States of America

                    

                  

                

        

      

      

      

      
        	
                

                

              	
                
                  Shengxin (Shanghai) Management Consulting

                  Limited Partnership

                  

                

              
	 	 
	

              	
                By:

              	
                /s/ Steven Huang

              
	
                

                

              	 	
                
                  Name: Steven Huang

                

              
	 	 	
                
                  Title: GP

                

              

      

      
        
          
             

            

            	
                     

                  	
                    Address:

                  	
                    Rm. 210-32, 2nd Fl. Building 1

                  
	
                     

                  	
                    
                      38 Debao Rd.

                    

                  
	
                     

                  	
                    
                      
                        Pilot Free Trade Zone

                      

                    

                  
	 	
                    
                      Shanghai, China

                    

                  

          

        

      

      

      

    

    
      Signature Page to Share Transfer and Note Cancellation Agreementwifi_Ex10_1

		

			 

		

		
			Exhibit 10.1
		

		
			 
		

		
			BOINGO WIRELESS, INC.
		

		
			10960 WILSHIRE BLVD., 23RD FLOOR
		

		
			LOS ANGELES, CA 90024
		

		
			 
		

		
			January 1, 2016
		

		
			Douglas Lodder
		

		
			313 N. Bronson Avenue
		

		
			Los Angeles, CA  90004
		

		
			 
		

		
			Dear Doug:
		

		
			Boingo Wireless, Inc. (the “Company”) is pleased to offer you continuing employment on the following terms, effective as of January 1, 2016 (the “Effective Date”).
		

		
			1.         Position. Your title and position with the Company will be Senior Vice President, Business Development, and you will report directly to David Hagan, Chief Executive Officer.  This is a full-time position and your place of employment will remain in our California Westwood office.  While you render services to the Company, you will not engage in any other employment, consulting or other business activity (whether full‐time or part-time) that would create a conflict of interest with the Company.  By signing this Agreement, you confirm to the Company that you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company.
		

		
			2.         Cash Compensation.  Beginning on the Effective Date, your annual base salary will be $240,000 per year, payable in accordance with the Company’s standard payroll schedule.  This salary will be subject to adjustment pursuant to the Company’s employee compensation policies in effect from time to time. In addition, you will continue to be eligible to be considered for a cash-incentive bonus for each fiscal year of the Company.  The bonus (if any) will be awarded based on objective or subjective criteria established and approved by the Compensation Committee of the Board.  Your target bonus will be equal to 55% of your annual base salary, measured as of the last day of each fiscal year.  Any bonus for a fiscal year or quarter will be paid within 21⁄2 months after the close of that fiscal year or quarter, but only if you are still employed by the Company at the time of payment.  The determinations of the Compensation Committee with respect to your bonus will be final and binding.
		

		
			3.         Employee Benefits.  As a regular employee of the Company, you will be eligible to participate in the Company’s standard employee benefits programs, as such are in effect from time to time.  In addition, you will be entitled to paid vacation in accordance with the Company’s vacation policy, as in effect from time to time.
		

		
			 
		

		
			 
		

		
			

		 

		

			 

		

		

			Page 2

		

		

		
			 
		

		
			4.         Payments Upon Termination.  If your employment with the Company terminates other than as set forth in Section 5 below, then (a) all vesting will cease immediately with respect to your then-outstanding Equity Awards and (b) the only amounts payable to you by the Company will be (i) any unpaid base salary due for periods prior to the date of termination of your employment and (ii) any accrued but unused vacation through such termination date.  Such payments, if any, will be made promptly upon termination and within the period of time mandated by law.
		

		
			5.         Severance Benefits.
		

		
			(a)        General.  If you are subject to an Involuntary Termination, then you will be entitled to the benefits described in this Section 5.  However, you will not be entitled to any of the benefits described in this Section 5 unless you have (i) returned all Company property in your possession, (ii) resigned as a member of the Board and of the boards of directors of all of the Company’s subsidiaries, to the extent applicable, and (iii) executed a general release of all claims that you may have against the Company or persons affiliated with the Company in a  form prescribed by the Company without alterations (the “Release”).  You must execute and return the release on or before the date specified by the Company in the Release (the “Release Deadline”).  The Release Deadline will in no event be later than fifty (50) days after your Separation.  If you fail to return the Release on or before the Release Deadline, or if you revoke the Release, then you will not be entitled to the benefits described in this Section 5.
		

		
			Notwithstanding the foregoing, the Company may immediately discontinue all benefits or revoke any vesting acceleration described in this Section 5 (in addition to pursuing all other legal and equitable remedies) if you breach the Employee Inventions and Confidentiality Agreement or the Mutual Agreement to Arbitrate Claims between you and the Company that you previously signed (collectively, the “Confidentiality Agreement”), a copy of which is attached hereto as Exhibit A, the terms of Section 7 below or any other material agreement with the Company that by its terms continues in force following your Separation.
		

		
			(b)        Termination Not in Connection With Change in Control.  Subject to the requirements set forth in Section 5(a) above, if you experience an Involuntary Termination either prior to a Change in Control or more than twelve (12) months after a Change in Control, then you will be entitled to the following:
		

		
			(i)         Salary Continuation.  The Company will continue to pay your base salary for a period beginning on the day after your Separation and ending on the date nine (9) months after your Separation. Your base salary will be paid at the rate in effect at the time of your Separation and in accordance with the Company’s standard payroll procedures.  Subject to the Company’s having first received an effective Release pursuant to Section 5(a) above, the salary continuation payments will commence within sixty (60) days after your Separation and, once they commence, will include any unpaid amounts accrued from the date of your Separation.  However, if the sixty (60)-day period described in the preceding sentence spans two calendar years, then the payments will in any event begin in the second calendar year.
		

		
			(ii)       Additional Payment in Lieu of Health Benefit.  The Company will pay you a lump sum amount equal to the product of (A) nine (9) and (B) the monthly
		

		
			
		

		
			

		 

		

			 

		

		

			Page 3

		

		

		
			 
		

		
			amount the Company was paying on behalf of you and your eligible dependents pursuant to the Company’s health insurance plans in which you or your dependents were participants as of the day of your Separation.  Subject to the Company’s having first received an effective Release pursuant to Section 5(a) above, such payment will be made within sixty (60) days after your Separation; however, if such sixty (60)-day period spans two calendar years, then the payment will be made in the second calendar year.
		

		
			(iii)      Equity Acceleration.  You will receive nine (9) months of vesting credit under your then-outstanding Equity Awards; provided, however, that in the event acceleration of the settlement or distribution date of an award would result in additional taxes and penalties under Section 409A of the Code, then the vesting of such award shall accelerate but settlement or distribution of award shares (or cash, if applicable) shall occur on the date(s) specified in the agreement governing the award.
		

		
			(c)        Termination in Connection With Change in Control.  Subject to the requirements set forth in Section 5(a) above, if you experience an Involuntary Termination within twelve (12) months following a Change in Control, then you will be entitled to the following:
		

		
			(i)         Salary Continuation.  The Company will continue to pay your base salary for a period beginning on the day after your Separation and ending on the date twelve (12) months after your Separation. Your base salary will be paid at the rate in effect at the time of your Separation and in accordance with the Company’s standard payroll procedures.  Subject to the Company’s having first received an effective Release pursuant to Section 5(a) above, the salary continuation payments will commence within sixty (60) days after your Separation and, once they commence, will include any unpaid amounts accrued from the date of your Separation.  However, if the sixty (60)-day period described in the preceding sentence spans two calendar years, then the payments will in any event begin in the second calendar year.
		

		
			(ii)       Target Bonus.  The Company will pay you a lump sum equal to your annual target bonus, net of any payment previously received, in the year of your Separation.  Subject to the Company’s having first received an effective Release pursuant to Section 5(a) above, such payment will be made within sixty (60) days after your Separation; however, if such sixty (60)-day period spans two calendar years, then the payment will be made in the second calendar year.
		

		
			(iii)      Additional Payment in Lieu of Health Benefit.  The Company will pay you a lump sum amount equal to the product of (A) twelve (12) and (B) the monthly amount the Company was paying on behalf of you and your eligible dependents pursuant to the Company’s health insurance plans in which you or your dependents were participants as of the day of your Separation.  Subject to the Company’s having first received an effective Release pursuant to Section 5(a) above, such payment will be made within sixty (60) days after your Separation; however, if such sixty (60)-day period spans two calendar years, then the payment will be made in the second calendar year.
		

		
			(iv)       Equity Acceleration.  You will receive full vesting credit under your then-outstanding Equity Awards; provided, however, that in the event acceleration of
		

		
			
		

		
			

		 

		

			 

		

		

			Page 4

		

		

		
			 
		

		
			the settlement or distribution date of an award would result in additional taxes and penalties under Section 409A of the Code, then the vesting of such award shall accelerate but settlement or distribution of award shares (or cash, if applicable) shall occur on the date(s) specified in the agreement governing the award.
		

		
			6.         Limitation on Payments.
		

		
			(a)        Scope of Limitation.  This Section 6 will apply only if the accounting firm serving as the Company’s independent public accountants immediately prior to a Change in Control (the “Accounting Firm”) determines that the after-tax value of all Payments (as defined below) to you under Section 5 of this Agreement, taking into account the effect of all federal, state and local income taxes, employment taxes and excise taxes applicable to you (including the excise tax under Section 4999 of the Code), will be greater after the application of this Section 6 than it was before the application of this Section 6.  If this Section 6 applies, it will supersede any contrary provision of this Agreement.  For purposes of this Section 6, the term “Company” will also include affiliated corporations to the extent determined by the Accounting Firm in accordance with Section 280G(d)(5) of the Code.
		

		
			(b)        Basic Rule.  In the event that the Accounting Firm determines that any payment or transfer by the Company to or for your benefit (a “Payment”) would be nondeductible by the Company for federal income tax purposes because of the provisions concerning “excess parachute payments” in Section 280G of the Code and pursuant to the regulations thereunder, then provided that Subsection (a) results in applicable of this Section 6, the aggregate present value of all Payments will be reduced (but not below zero) to the Reduced Amount.  For purposes of this Section 6, the “Reduced Amount” will be the amount, expressed as a present value, which maximizes the aggregate present value of the Payments without causing any Payment to be nondeductible by the Company because of Section 280G of the Code.
		

		
			(c)        Reduction of Payments.  If the Accounting Firm determines that any Payment would be nondeductible by the Company because of Section 280G of the Code, and if none of the Payments is subject to Section 409A of the Code, then the reduction will occur in the manner you elect in writing prior to the date of payment; provided, however, that if the manner elected by you pursuant to this sentence could in the opinion of the Company result in any of the Payments becoming subject to Section 409A of the Code, then the following sentence will instead apply.  If any Payment is subject to Section 409A of the Code, or if you fail to elect an order under the preceding sentence, then the reduction will occur in the following order: (i) cancellation of acceleration of vesting of any Equity Awards for which the exercise price (if any) exceeds the then-fair market value of the underlying Stock; (ii) reduction of cash payments (with such reduction being applied to the payments in the reverse order in which they would otherwise be made (that is, later payments will be reduced before earlier payments)); and (iii) cancellation of acceleration of vesting of Equity Awards not covered under (i) above; provided, however, that in the event that acceleration of vesting of Equity Awards is to be cancelled, such acceleration of vesting will be cancelled in the reverse order of the date of grant of such Equity Awards (that is, later Equity Awards will be canceled before earlier Equity Awards).
		

		
			(d)        Fees of Accounting Firm and Required Data.  The Company will pay all fees, expenses and other costs associated with retaining the Accounting Firm for the purposes
		

		
			
		

		
			

		 

		

			 

		

		

			Page 5

		

		

		
			 
		

		
			described in this Section 6.  You and the Company will provide to the Accounting Firm all data in the Company’s possession or under its control that the Accounting Firm reasonably requires for the purposes described in this Section 6.
		

		
			7.         Further Obligations to the Company.
		

		
			(a)        General.  You acknowledge your obligations under, and agree to comply with, all applicable laws and all Company policies in effect at all times and from time to time during your employment with the Company.  You further acknowledge and agree that such applicable laws or policies may relate to the general terms of your employment with the Company or to a specific component of your compensation. By way of example, such applicable laws or policies may include any Company recoupment or clawback policy, insider trading policy or code(s) of conduct or other policies adopted under, pursuant to or in light of, or requirements imposed by, the Sarbanes-Oxley Act of 2002 or the Dodd-Frank Wall Street Reform and Consumer Protection Act.
		

		
			(b)        Confidential Information.  You agree to execute such additional documents as may be necessary to protect the Company’s confidential and proprietary information, which such documents will supplement the Confidentiality Agreement (which such agreement will continue in full force and effect).
		

		
			8.         Employment Relationship.  Employment with the Company is for no specific period of time.  Your employment with the Company remains “at will,” meaning that either you or the Company may terminate your employment at any time and for any reason, with or without cause.  Any contrary representations that may have been made to you are superseded by this Agreement.  This is the full and complete agreement between you and the Company on this term.  Although your job duties, title, compensation and benefits, as well as the Company’s personnel policies and procedures, may change from time to time, the “at will” nature of your employment may only be changed in an express written agreement signed by you and a duly authorized officer of the Company (other than you).
		

		
			9.         Tax Matters.
		

		
			(a)        General.  All forms of compensation referred to in this Agreement are subject to reduction to reflect applicable withholding and payroll taxes and other deductions required by law. You are encouraged to obtain your own tax advice regarding your compensation from the Company.  You agree that the Company does not have a duty to design its compensation policies in a manner that minimizes your tax liabilities, and you will not make any claim against the Company or its Board related to tax liabilities arising from your compensation.
		

		
			(b)        Section 409A.  For purposes of Section 409A of the Code, each payment under Section 5 is hereby designated as a separate payment for purposes of Treasury Regulation 1.409A-2(b)(2).  If the Company determines that you are a “specified employee” under Section 409A(a)(2)(B)(i) of the Code at the time of your Separation, then (i) any payments under this Agreement, to the extent that they are not exempt from Section 409A of the Code (including by operation of the next following sentence) and otherwise subject to the taxes imposed under Section 409A(a)(1) of the Code (a “Deferred Payment”), will commence on the first business day
		

		
			
		

		
			

		 

		

			 

		

		

			Page 6

		

		

		
			 
		

		
			following (A) the expiration of the six-month period measured from your Separation or (B) the date of your death and (ii) the installments that otherwise would have been paid prior to such date will be paid in a lump sum when such payments commence.  Notwithstanding the foregoing, any amount paid under this Agreement that either (1) satisfies the requirements of the “short-term deferral” rule set forth in Treasury Regulation 1.409A-1(b)(4); or (2) (A) qualifies as a payment made as a result of an involuntary separation from service pursuant to Treasury Regulation 1.409A-1(b)(9)(iii), and (B) does not exceed the Section 409A Limit will not constitute a Deferred Payment.  The provisions of this Agreement are intended to comply with, or be exempt from, the requirements of Section 409A of the Code so that none of the payments and benefits to be provided under this Agreement will be subject to the additional tax imposed under Section 409A of the Code, and any ambiguities herein will be interpreted to so comply or be exempt. You and the Company agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions as are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to you under Section 409A of the Code. In no event will the Company reimburse you for any taxes that may be imposed on you as result of Section 409A of the Code.
		

		
			10.       Interpretation, Amendment and Enforcement.  Upon the Effective Date, this Agreement will constitute the complete agreement between you and the Company, contain all of the terms of your employment with the Company and supersede and replace any prior agreements, policies, representations or understandings (whether written, oral, implied or otherwise) between you and the Company, including your participation in the Company’s Severance Benefits Policy.  This Agreement may not be amended or modified, except by an express written agreement signed by both you and a duly authorized officer of the Company.  The terms of this Agreement and the resolution of any disputes as to the meaning, effect, performance or validity of this Agreement or arising out of, related to, or in any way connected with, this Agreement, your employment with the Company or any other relationship between you and the Company (the “Disputes”) will be governed by California law, excluding laws relating to conflicts or choice of law.  You and the Company submit to the exclusive personal jurisdiction of the federal and state courts located in California in connection with any Dispute or any claim related to any Dispute.  By signing this Agreement, you acknowledge and agree that you will no longer be eligible for any benefits or payments provided for in any such prior agreement, except as otherwise expressly provided in this Agreement.
		

		
			11.       Successors and Assignment.
		

		
			(a)        Company’s Successors.  Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets will assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession.  For all purposes under this Agreement, the term “Company” shall include any such successor to the Company, or to the Company’s business and/or assets, that executes and delivers the assumption agreement described in this Section 11(a) or which becomes bound by the terms of this Agreement by operation of law.
		

		
			(b)        Employee’s Successors.  The terms of this Agreement and all of your rights hereunder will inure to the benefit of, and be enforceable by, your personal or legal representatives,
		

		
			
		

		
			

		 

		

			 

		

		

			Page 7

		

		

		
			 
		

		
			executors, administrators, successors, heirs, distributees, devisees and legatees.  All of your obligations under this Agreement are personal to you and may not be transferred or assigned by you at any time.
		

		
			12.       Definitions.  The following terms have the meaning set forth below wherever they are used in this Agreement:
		

		
			“Board” means the Company’s Board of Directors.
		

		
			“Cause” means the occurrence of any one or more of the following: (a) your conviction by, or entry of a plea of “guilty” or nolo contendere in, a court of competent jurisdiction for any crime which constitutes a felony in the jurisdiction involved, (b) your commission of an act of theft or fraud, whether prior or subsequent to the date hereof, upon the Company, (c) your gross negligence in the scope of your services to the Company, (d) your breach of a material provision of any written agreement between you and the Company, (e) your continuing failure to perform assigned duties after receiving written notification of such failure from the Chief Executive Officer or (f) your failure to cooperate in good faith with a governmental or internal investigation of the Company or its directors, officers or employees, if the Company has requested your cooperation.
		

		
			“Change in Control” means (a) any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company’s then-outstanding voting securities; (b) the consummation of the sale or disposition by the Company of all or substantially all of the Company’s assets; (c) the consummation of a merger or consolidation of the Company with or into any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation; or (d) individuals who are members of the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the members of the Board over a period of twelve (12) months; provided, however, that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member shall, for purposes of this Agreement, be considered as a member of the Incumbent Board.
		

		
			A transaction will not constitute a Change in Control if its sole purpose is to change the state of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.  In addition, if a Change in Control constitutes a payment event with respect to any Equity Award which provides for a deferral of compensation and is subject to Section 409A of the Code, then notwithstanding anything to the contrary in this Agreement, the transaction with respect to such Equity Award must also constitute a “change in control event” as defined in Treasury Regulation 1.409A-3(i)(5) to the extent required by Section 409A of the Code.
		

		
			
		

		
			

		 

		

			 

		

		

			Page 8

		

		

		
			 
		

		
			“Code” means the Internal Revenue Code of 1986, as amended.
		

		
			“Equity Awards” means (a) all shares of Stock; (b) all options and other rights to purchase shares of Stock; (c) all stock units, performance units or phantom shares whose value is measured by the value of shares of Stock; and (d) all stock appreciation rights whose value is measured by increases in the value of shares of Stock.
		

		
			“Exchange Act” means the Securities Exchange Act of 1934, as amended.
		

		
			“Involuntary Termination” means either (a) your Termination Without Cause (other than due to your death or Permanent Disability) or (b) your Resignation for Good Reason.
		

		
			“Permanent Disability” means your total and permanent disability as defined in Section 22(e)(3) of the Code.
		

		
			“Resignation for Good Reason” means a Separation as a result of your resignation within twelve (12) months after one of the following conditions initially has come into existence without your express written consent:
		

		
			i.          A material reduction of your duties, authority and responsibilities, relative to your duties, authority and responsibilities as in effect immediately prior to such reduction, or the assignment to you of such reduced duties, authority and responsibilities;
		

		
			ii.         A reduction in your base salary in effect immediately prior to such reduction;
		

		
			iii.        A material reduction in the kind or level of employee benefits to which you were entitled immediately prior to such reduction, with the result that your overall benefits package is materially reduced;
		

		
			iv.        A relocation to a facility or a location more than thirty-five miles from your then-present location that increases your one-way commute; or
		

		
			v.         The Company’s breach of this Agreement, including its failure to obtain the assumption of this Agreement by any successor (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets.
		

		
			A Resignation for Good Reason will not be deemed to have occurred unless you give the Company written notice of the condition within ninety (90) days after the condition initially comes into existence and the Company fails to remedy the condition within thirty (30) days after receiving your written notice.
		

		
			“Section 409A Limit” means the lesser of two times: (i) your annualized compensation based upon the annual rate of pay paid to you during the taxable year preceding your taxable year in which your termination of employment occurs, as determined under, and with such adjustments as are set forth in, Treasury Regulation  1.409A-1(b)(9)(iii)(A)(1) and any guidance
		

		
			
		

		
			

		 

		

			 

		

		

			Page 9

		

		

		
			 
		

		
			issued with respect thereto or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which your employment is terminated.
		

		
			“Separation” means a “separation from service,” as defined in the regulations under Section 409A of the Code.
		

		
			  “Stock” means the Common Stock of the Company.
		

		
			“Termination Without Cause” means a Separation as a result of a termination of your employment by the Company without Cause, provided you are willing and able to continue performing services within the meaning of Treasury Regulation 1.409A-1(n)(1).
		

		
			* * * * *
		

		
			 
		

		
			
		

		
			

		 

		

			 

		

		

			Page 10

		

		

		
			 
		

		
			You may indicate your agreement with these terms and accept this offer by signing and dating the enclosed duplicate original of this Agreement and returning it to me.
		

		
			 
		

			
					
						 

					
					
						Very truly yours,

				
	
					
						 

					
					
						BOINGO WIRELESS, INC.

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						By:

					
					
						/s/  David Hagan

				
	
					
						 

					
					
						Title:

					
					
						Chairman & CEO

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						I have read and accept this employment offer:

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						/s/  Douglas Lodder

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						Signature of Douglas Lodder

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						Dated: 

					
					
						3/16/16

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

				
	
					
						Exhibit A:      Confidentiality Agreement (previously signed)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}]]